When oral medicines for Chronic Myeloid Leukemia (CML) first became available, they dramatically changed what it meant to ...

Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Cycle ...

If approved, Scemblix will be indicated for adults with chronic myeloid leukemia (CML), both newly diagnosed and previously treated, expanding access to four times as many patients in EuropeScemblix ...

The FDA has issued a complete response letter (CRL) to a new drug application (NDA) for Dasynoc for the treatment of chronic ...

Mendus has announced a strategy update, unveiling plans to expand the application of vididencel beyond the current lead programme in acute myeloid leukaemia (AML), to chronic myeloid leukaemia (CML).

Swedish oncology specialist Xspray Pharma has received a complete response letter (CRL) from the US Food and Drug ...

WWE stars Roman Reigns, Bret Hart, Michelle McCool, Alexa Bliss, and John Cena bravely battled serious illnesses like ...

The event will feature an overview of the ongoing Phase 3 REGAL trial of GPS (results expected by year-end) and a discussion of the unmet needs of AML patients in complete second remission (CR2).

2025 BofA China Trailblazers Biotech Conference: One-on-one investor meetings on October 20-21 ...

After Novartis (NVS) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive ...

A concerning development has surfaced around Roman Reigns' health after his heartbreaking loss against Bronson Reed at Crown Jewel 2025.

July 2025: Taiho Oncology and Taiho Pharmaceutical announced the FDA’s acceptance of a supplemental New Drug Application for ...